Aberrations in the enzymes that modify ubiquitin moieties have been observed to cause a myriad of diseases, including cancer. Therefore a better understanding of these enzymes and their substrates will lead to the identification of prospective druggable targets. Here we discuss the role of ubiquitin modifying enzymes in the canonical TGF-β pathway highlighting the ubiquitin regulating enzymes, which may potentially be targeted by small molecule inhibitors.
Visit the following link for full text of the article: http://www.jscholaronline.org/full-text/JCRTO/102/(de)-ubiquitination-in-the-tgf-beta-pathway
Visit the following link for full text of the article: http://www.jscholaronline.org/full-text/JCRTO/102/(de)-ubiquitination-in-the-tgf-beta-pathway
No comments:
Post a Comment